Skip to main content

Advertisement

ADVERTISEMENT

Exclusives

News
04/01/2024
A 5,000-patient clinical registry will collect data on safety and efficacy of advanced wound treatment modalities in medical centers with primary outcome of data collected at 5 years for advanced therapies versus rate of healing. Not yet...
A 5,000-patient clinical registry will collect data on safety and efficacy of advanced wound treatment modalities in medical centers with primary outcome of data collected at 5 years for advanced therapies versus rate of healing. Not yet...
A 5,000-patient clinical...
04/01/2024
Wound Care
News
04/01/2024
A Phase II 60-patient RCT will examine the safety of subcutaneous tumescent antibiotic administration and compare with SoC for the treatment of chronic wounds with primary outcome of rate of occurrence and severity of adverse events up to 6...
A Phase II 60-patient RCT will examine the safety of subcutaneous tumescent antibiotic administration and compare with SoC for the treatment of chronic wounds with primary outcome of rate of occurrence and severity of adverse events up to 6...
A Phase II 60-patient RCT will...
04/01/2024
Wound Care
News
04/01/2024
A 53-patient study examining the correlation between sub-epidermal moisture and Braden scores among ICU patients found that the median baseline Braden score was 9, and 81% of patients were at very high/high risk of pressure ulcer development....
A 53-patient study examining the correlation between sub-epidermal moisture and Braden scores among ICU patients found that the median baseline Braden score was 9, and 81% of patients were at very high/high risk of pressure ulcer development....
A 53-patient study examining the...
04/01/2024
Wound Care
News
04/01/2024
SNN will sponsor a single-centered observational study of 23 patients using the RENASYS Film with AIRLOCK Technology on chronic and acute wounds. The primary objective is to evaluate the percentage of wounds progressing to healing at the end...
SNN will sponsor a single-centered observational study of 23 patients using the RENASYS Film with AIRLOCK Technology on chronic and acute wounds. The primary objective is to evaluate the percentage of wounds progressing to healing at the end...
SNN will sponsor a...
04/01/2024
Wound Care
News
04/01/2024
A 10-patient open-label pilot study of self-adjustable short-stretch compression garments (SSCG), prefitted using portable, 3-dimensional infrared imaging (3DII), showed an 11.3% limb volume reduction after 2 weeks and may be an option in...
A 10-patient open-label pilot study of self-adjustable short-stretch compression garments (SSCG), prefitted using portable, 3-dimensional infrared imaging (3DII), showed an 11.3% limb volume reduction after 2 weeks and may be an option in...
A 10-patient open-label pilot...
04/01/2024
Wound Care
News
03/26/2024
A 120-patient study examined the effect of honey and hydrogel products on healing time in diabetic foot cases. The study found that the mean healing time for honey alone, Hydrogel alone and halo alternately were 12.20, 13.83, and 10.83 days,...
A 120-patient study examined the effect of honey and hydrogel products on healing time in diabetic foot cases. The study found that the mean healing time for honey alone, Hydrogel alone and halo alternately were 12.20, 13.83, and 10.83 days,...
A 120-patient study examined the...
03/26/2024
Wound Care
News
03/26/2024
A study of 300 patients with type 2 diabetes (T2D) and DFUs treated in a tertiary-care center found patients with high glucose variability (GV) had a 3-fold higher risk of healing failure versus a low GV. Results conclude GV is a risk factor...
A study of 300 patients with type 2 diabetes (T2D) and DFUs treated in a tertiary-care center found patients with high glucose variability (GV) had a 3-fold higher risk of healing failure versus a low GV. Results conclude GV is a risk factor...
A study of 300 patients with...
03/26/2024
Wound Care
News
03/26/2024
A 40-patient RCT will evaluate the safety and efficacy of topically applied PEP-TISSEEL in subjects with DFUs. Primary endpoints are complete wound closure at 12 weeks and dose-limiting toxicity events at 6 months. Recruitment is ongoing with...
A 40-patient RCT will evaluate the safety and efficacy of topically applied PEP-TISSEEL in subjects with DFUs. Primary endpoints are complete wound closure at 12 weeks and dose-limiting toxicity events at 6 months. Recruitment is ongoing with...
A 40-patient RCT will evaluate...
03/26/2024
Wound Care
News
03/26/2024
MiMedx announced it has entered into an agreement with TELA Bio to obtain exclusive rights to its manufacturing and supply agreement with Regenity Biosciences that will enable the company to add xenograft products to its portfolio of Advanced...
MiMedx announced it has entered into an agreement with TELA Bio to obtain exclusive rights to its manufacturing and supply agreement with Regenity Biosciences that will enable the company to add xenograft products to its portfolio of Advanced...
MiMedx announced it has entered...
03/26/2024
Wound Care
News
03/26/2024
In its Q423 results, MediWound stated that the EscharEx Phase III study protocol has been aligned with the FDA and EMA, and a final protocol is expected to be submitted in H124. The 216-patient 40 site study is anticipated to begin in H224....
In its Q423 results, MediWound stated that the EscharEx Phase III study protocol has been aligned with the FDA and EMA, and a final protocol is expected to be submitted in H124. The 216-patient 40 site study is anticipated to begin in H224....
In its Q423 results, MediWound...
03/26/2024
Wound Care

Advertisement

Advertisement

Advertisement